| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/04/2004 | EP1386279A2 Method for inhibiting metap2 |
| 02/04/2004 | EP1386165A2 Inflammatory markers for detection and prevention of diabetes mellitus |
| 02/04/2004 | EP1386155A2 Therapeutic and diagnostic uses of antibody specificity profiles |
| 02/04/2004 | EP1385977A2 Secreted proteins |
| 02/04/2004 | EP1385970A1 A method for preparing lactic acid fermented solution of mushroom and lactic acid fermented solution of mushroom produced thereby |
| 02/04/2004 | EP1385953A2 Proteins and nucleic acids encoding same |
| 02/04/2004 | EP1385952A2 Methods of inhibiting expression of a target gene in mammalian cells |
| 02/04/2004 | EP1385935A1 Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway |
| 02/04/2004 | EP1385934A2 Pufa polyketide synthase systems and uses thereof |
| 02/04/2004 | EP1385883A2 Transmembrane proteins |
| 02/04/2004 | EP1385881A1 Anti-obesity polypeptides |
| 02/04/2004 | EP1385868A2 Steroidal derivatives |
| 02/04/2004 | EP1385864A1 Vascular endothelial growth factor 2 |
| 02/04/2004 | EP1385856A2 Amino acid complexes of c-aryl glucosides for treatment of diabetes and method |
| 02/04/2004 | EP1385845A1 N-aroyl cyclic amines |
| 02/04/2004 | EP1385842A1 Heterocyclyloxy-, -thioxy- and -aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 02/04/2004 | EP1385841A1 Sulfonamides |
| 02/04/2004 | EP1385840A1 Sulfonamides |
| 02/04/2004 | EP1385835A1 Benzoxazinone derivatives for use in the treatment of angiogenesis |
| 02/04/2004 | EP1385830A1 Sulfonamides |
| 02/04/2004 | EP1385825A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 02/04/2004 | EP1385823A1 Novel guanidino compounds |
| 02/04/2004 | EP1385550A2 Therapeutic method for inducing tolerance |
| 02/04/2004 | EP1385549A2 Combination of nateglinide or repaglinide with at least one further antidiabetic compound |
| 02/04/2004 | EP1385548A2 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions |
| 02/04/2004 | EP1385532A1 Stimulation of osteogenesis using rank ligand fusion proteins |
| 02/04/2004 | EP1385524A1 Pyrazolopyrimidines as therapeutic agents |
| 02/04/2004 | EP1385518A1 Benzimidazolone compounds |
| 02/04/2004 | EP1385514A1 Spiroindene and spiroindane compounds |
| 02/04/2004 | EP1385509A1 Method of treatment |
| 02/04/2004 | EP1385508A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 02/04/2004 | EP1385507A1 Sulfonamides |
| 02/04/2004 | EP1385506A2 Acylated piperidine derivates as melanocortin-4 receptor agonists |
| 02/04/2004 | EP1385503A1 The use of enantiomeric pure escitalopram |
| 02/04/2004 | EP1385501A2 Probucol monoesters and their use to increase plasma hdl cholesterol levels and improve hdl functionality |
| 02/04/2004 | EP1385499A1 Method for improving the well-being of poultry by in-ovo injection of carnitine |
| 02/04/2004 | EP1385498A2 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 02/04/2004 | EP1385496A2 Use of compositions for treating rosacea |
| 02/04/2004 | EP1385495A2 Sulfonamides |
| 02/04/2004 | EP1385493A1 Substituted cyclohexan-1,4-diamine derivatives with constipating and peripheral analgesic properties |
| 02/04/2004 | EP1385476A2 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions |
| 02/04/2004 | EP1339416A4 Trace elements |
| 02/04/2004 | EP1257304B1 Foam-forming wound dressing |
| 02/04/2004 | EP1216041B1 High lipid diet |
| 02/04/2004 | EP1115697B1 Unsaturated hydroximic acid derivatives as parp inhibitors |
| 02/04/2004 | EP1076650B1 Aryl fused azapolycyclic compounds |
| 02/04/2004 | EP1021196B1 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 02/04/2004 | EP1010424B1 Liver fat accumulation inhibitory composition, food additive for liver fat accumulation inhibition, and method of inhibiting liver fat accumulation |
| 02/04/2004 | EP0992503B1 Process for producing isooxazolidinedione compound |
| 02/04/2004 | CN1473163A Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors |
| 02/04/2004 | CN1473161A Pyrazole compounds as protein kinase inhibitors |
| 02/04/2004 | CN1473156A Pyrimidine derivatives and their use as neuropeptide y receptor ligands |
| 02/04/2004 | CN1473151A Crystalline forms of fluvastatin sodium |
| 02/04/2004 | CN1473144A Solid compositions suitable for oral administration containing non-hydroscopic salts of L-carnitine and alkanoyl L-carnitines with taurine chloride and glycine chloride |
| 02/04/2004 | CN1473053A High-density lipoprotein-cholesterol level elevating agent |
| 02/04/2004 | CN1473050A Use of long pentraxin PTX3 for treatment of diseases caused by altered activation of growth factor FGF-2 |
| 02/04/2004 | CN1473048A 1 alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications |
| 02/04/2004 | CN1473047A Method for treating hypogonadism |
| 02/04/2004 | CN1473042A Medical compositions |
| 02/04/2004 | CN1473040A Association and medicinal composition of CB1 receptor antagonist and sibutramin for treating obesity |
| 02/04/2004 | CN1472218A Medicine compound for preventing diabets mellitus and preparing method thereof |
| 02/04/2004 | CN1472217A Aminoglucose acid, chromium complex with its derivative and preparation and use thereof |
| 02/04/2004 | CN1471949A Capsules for nourishing yin and reducing blood sugar |
| 02/04/2004 | CN1471947A Natural weight-reducing medicine |
| 02/04/2004 | CN1471944A Preparing method and use for Chinese medicine extractive with alpha-glucoside inhibiting activity |
| 02/04/2004 | CN1471934A Alpha-glycosidase inhibitor and its use |
| 02/04/2004 | CN1471921A Use of chitin oligosaccharide sulphate and/or chitin sulfate for preparing medicine for diabetes |
| 02/04/2004 | CN1471919A Use of allose alcohol in preparing medicine for diabetes |
| 02/04/2004 | CN1471912A Oral film agent of vanadium biguanide complex for diabetes and its use |
| 02/04/2004 | CN1471911A Oral film agent of vanadium biguanide complex for diabetes and its use |
| 02/04/2004 | CN1471902A River points line and its production and use for curing coronary, diabetes and enterogastric ulcers |
| 02/04/2004 | CN1471846A Healthy food for balancing blood pressure and regulating blood fat and preparing method thereof |
| 02/04/2004 | CN1137259C Antilipemic health vinegar |
| 02/04/2004 | CN1137133C Preparation of sterol and dihydro-sterol ester |
| 02/04/2004 | CN1137125C Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| 02/04/2004 | CN1137123C Azolo triazizes and pyrimidines |
| 02/04/2004 | CN1137097C Aminoalkyl-3,4-dihydroquindine derivates as No-synthase inhibitors |
| 02/04/2004 | CN1136893C Medicine for curing diabetes |
| 02/04/2004 | CN1136891C Freeze dried compound queen bee powder |
| 02/04/2004 | CN1136876C Medicine for treating diabetes and its preparing process |
| 02/04/2004 | CN1136874C Composite medicine for treating hyperlipemia |
| 02/04/2004 | CN1136873C Composite medicine for treating hyperglycaemia |
| 02/04/2004 | CN1136855C Cross-linked polymers for removing bile salts from patient |
| 02/04/2004 | CN1136792C Process for preparing additive rich in organic iodine compound from plant |
| 02/03/2004 | US6686481 Highly purified simvastatin compositions |
| 02/03/2004 | US6686467 Inhibitors of the production of cytokines such as tumour necrosis factor (hereinafter tnf), for example tnf alpha , and various members of the interleukin (hereinafter il) family, for example il-1, il-6 and il-8 |
| 02/03/2004 | US6686397 Polysubstituted indan-1-ol systems for the prophylaxis or treatment of obesity |
| 02/03/2004 | US6686386 Combating photoinduced or chronological ageing of skin with retenoic acid receptor agonist |
| 02/03/2004 | US6686384 2-anilinophenyl-substituted; inhibition of the na+/h+ exchanger |
| 02/03/2004 | US6686383 Treatment of diabetic nephropathy with a biphenyl-4-yl)alkyl-1h-benzimidazole compounds |
| 02/03/2004 | US6686381 Compounds that antagonize neuropeptide y at the y5 receptor subtype represent an approach to the treatment of eating disorders such as obesity and hyperphagia |
| 02/03/2004 | US6686373 Analgesics; antiinflammatory agent |
| 02/03/2004 | US6686372 Selective β3 adrenergic agonists |
| 02/03/2004 | US6686367 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants |
| 02/03/2004 | US6686351 Compounds and methods for modulation of estrogen receptors |
| 02/03/2004 | US6686349 Administering to a patient for the treatment of sexual dysfunction an effective amount of substituted tetracyclic pyrroloquinolone derivatives |
| 02/03/2004 | US6686347 Phthalazine derivatives for treating inflammatory diseases |
| 02/03/2004 | US6686337 Combination therapy comprising anti-diabetic and anticonvulsant agents |
| 02/03/2004 | US6686177 Delayed onset of action |
| 02/03/2004 | US6685967 Spray dried powder |